BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 35168419)

  • 41. Embryonal central neuroepithelial tumors and their differentiating potential. A cytogenetic view of a complex neuro-oncological problem.
    Rubinstein LJ
    J Neurosurg; 1985 Jun; 62(6):795-805. PubMed ID: 2987439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.
    Komori T
    Neurol Med Chir (Tokyo); 2017 Jul; 57(7):301-311. PubMed ID: 28592714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent advances in embryonal tumours of the central nervous system.
    Sarkar C; Deb P; Sharma MC
    Childs Nerv Syst; 2005 Apr; 21(4):272-93. PubMed ID: 15682321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence, Trends, and Survival of Children With Embryonal Tumors.
    Tulla M; Berthold F; Graf N; Rutkowski S; von Schweinitz D; Spix C; Kaatsch P
    Pediatrics; 2015 Sep; 136(3):e623-32. PubMed ID: 26304823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Germ cell and embryonal tumors].
    Reith W; Mühl-Benninghaus R; Simgen A; Yilmaz U
    Radiologe; 2014 Aug; 54(8):772-82. PubMed ID: 25119569
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Beckmann PJ; Larson JD; Larsson AT; Ostergaard JP; Wagner S; Rahrmann EP; Shamsan GA; Otto GM; Williams RL; Wang J; Lee C; Tschida BR; Das P; Dubuc AM; Moriarity BS; Picard D; Wu X; Rodriguez FJ; Rosemarie Q; Krebs RD; Molan AM; Demer AM; Frees MM; Rizzardi AE; Schmechel SC; Eberhart CG; Jenkins RB; Wechsler-Reya RJ; Odde DJ; Huang A; Taylor MD; Sarver AL; Largaespada DA
    Cancer Res; 2019 Mar; 79(5):905-917. PubMed ID: 30674530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
    Wood MD; Halfpenny AM; Moore SR
    Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of bevacizumab, irinotecan, and temozolomide combination for relapsed or refractory pediatric central nervous system embryonal tumor: a single-institution study.
    Shiba Y; Motomura K; Taniguchi R; Kurimoto M; Mizutani K; Ohka F; Aoki K; Ito E; Nishikawa T; Yamaguchi J; Kibe Y; Shimizu H; Maeda S; Nakashima T; Suzuki H; Muramatsu H; Takahashi Y; Saito R
    J Neurosurg Pediatr; 2023 Mar; ():1-9. PubMed ID: 36905668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Population-based analysis of CNS tumor diagnoses, treatment, and survival in congenital and infant age groups.
    Hart M; Anderson-Mellies A; Beltrami A; Gilani A; Green AL
    J Neurooncol; 2022 Apr; 157(2):333-344. PubMed ID: 35175546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Embryonal Tumors of the Central Nervous System in Children: The Era of Targeted Therapeutics.
    Kram DE; Henderson JJ; Baig M; Chakraborty D; Gardner MA; Biswas S; Khatua S
    Bioengineering (Basel); 2018 Sep; 5(4):. PubMed ID: 30249036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C19MC amplification and expression of Lin28A and Olig2 in the classification of embryonal tumors of the central nervous system: A 14-year retrospective study from a tertiary care center.
    Nambirajan A; Gurung N; Suri V; Sarkar C; Kumar A; Singh M; Sharma MC
    Childs Nerv Syst; 2021 Apr; 37(4):1067-1075. PubMed ID: 33236184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Embryonal tumors in Canadian children less than 36 months of age: results from the Canadian Pediatric Brain Tumor Consortium (CPBTC).
    Story E; Johnston DL; Bartels U; Carret AS; Crooks B; Eisenstat DD; Fryer C; Lafay-Cousin L; Larouche V; Wilson B; Zelcer S; Silva M; Brossard J; Bouffet E; Keene DL
    J Neurooncol; 2017 Jul; 133(3):581-587. PubMed ID: 28508928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entities.
    Korshunov A; Jakobiec FA; Eberhart CG; Hovestadt V; Capper D; Jones DT; Sturm D; Stagner AM; Edward DP; Eagle RC; Proia AD; Koch A; Ryzhova M; Ektova A; Schüller U; Zheludkova O; Lichter P; von Deimling A; Pfister SM; Kool M
    Neuropathology; 2015 Dec; 35(6):538-44. PubMed ID: 26183384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medulloblastoma: WHO 2021 and Beyond.
    Cotter JA; Hawkins C
    Pediatr Dev Pathol; 2022; 25(1):23-33. PubMed ID: 35168417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.
    Sturm D; Orr BA; Toprak UH; Hovestadt V; Jones DTW; Capper D; Sill M; Buchhalter I; Northcott PA; Leis I; Ryzhova M; Koelsche C; Pfaff E; Allen SJ; Balasubramanian G; Worst BC; Pajtler KW; Brabetz S; Johann PD; Sahm F; Reimand J; Mackay A; Carvalho DM; Remke M; Phillips JJ; Perry A; Cowdrey C; Drissi R; Fouladi M; Giangaspero F; Łastowska M; Grajkowska W; Scheurlen W; Pietsch T; Hagel C; Gojo J; Lötsch D; Berger W; Slavc I; Haberler C; Jouvet A; Holm S; Hofer S; Prinz M; Keohane C; Fried I; Mawrin C; Scheie D; Mobley BC; Schniederjan MJ; Santi M; Buccoliero AM; Dahiya S; Kramm CM; von Bueren AO; von Hoff K; Rutkowski S; Herold-Mende C; Frühwald MC; Milde T; Hasselblatt M; Wesseling P; Rößler J; Schüller U; Ebinger M; Schittenhelm J; Frank S; Grobholz R; Vajtai I; Hans V; Schneppenheim R; Zitterbart K; Collins VP; Aronica E; Varlet P; Puget S; Dufour C; Grill J; Figarella-Branger D; Wolter M; Schuhmann MU; Shalaby T; Grotzer M; van Meter T; Monoranu CM; Felsberg J; Reifenberger G; Snuderl M; Forrester LA; Koster J; Versteeg R; Volckmann R; van Sluis P; Wolf S; Mikkelsen T; Gajjar A; Aldape K; Moore AS; Taylor MD; Jones C; Jabado N; Karajannis MA; Eils R; Schlesner M; Lichter P; von Deimling A; Pfister SM; Ellison DW; Korshunov A; Kool M
    Cell; 2016 Feb; 164(5):1060-1072. PubMed ID: 26919435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Review of the Recent Changes in the WHO Classification for Pediatric Brain and Spinal Cord Tumors.
    Halfpenny AM; Wood MD
    Pediatr Neurosurg; 2023; 58(5):337-355. PubMed ID: 36617415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medulloblastoma/Primitive neuroectodermal tumor and germ cell tumors: the uncommon but potentially curable primary brain tumors.
    Samkari A; Hwang E; Packer RJ
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):881-95. PubMed ID: 22794288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mouse models of CNS embryonal tumors.
    Momota H; Holland EC
    Brain Tumor Pathol; 2009; 26(2):43-50. PubMed ID: 19856214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
    Kellie SJ; Wong CK; Pozza LD; Waters KD; Lockwood L; Mauger DC; White L
    Med Pediatr Oncol; 2002 Sep; 39(3):168-74. PubMed ID: 12210445
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imaging Characteristics of CNS Neuroblastoma-
    Tietze A; Mankad K; Lequin MH; Ivarsson L; Mirsky D; Jaju A; Kool M; Hoff KV; Bison B; Löbel U
    AJNR Am J Neuroradiol; 2022 Oct; 43(10):1476-1480. PubMed ID: 36137662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.